Building Effective Multimodal Care for Obesity and Comorbidities in the GLP-1 Therapy Era.

Multimodal management of obesity, including behavioral therapy and early intervention, is essential in the GLP-1 therapy era to improve outcomes.

• Why it matters: Current approaches often focus narrowly on pharmacological treatment, neglecting the comprehensive care needed to address obesity and its comorbidities effectively across a person's life.
• What they did: The perspective advocates for integrating screening, early management, and intensive behavioral therapy into obesity care, emphasizing a holistic, lifelong approach.
• The result: Implementing multimodal strategies can enhance treatment effectiveness, reduce obesity-related health issues, and better support individuals throughout their lifespan.